Legal Representation
Attorney
John L. Haller
USPTO Deadlines
Application History
8 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| May 2, 2016 | ABN2 | O | ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE | Loading... |
| May 2, 2016 | MAB2 | O | ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND | Loading... |
| Oct 2, 2015 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Oct 2, 2015 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Oct 2, 2015 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Oct 2, 2015 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Jul 3, 2015 | MDSM | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 2, 2015 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
Detailed Classifications
Class 045
Anti-Cancer Virus provided to select members of the public in clinical trials
First Use Anywhere:
Feb 1, 2009
First Use in Commerce:
Feb 1, 2009
Additional Information
Design Mark
The mark consists of a pattern of circles where the interior circles are conjoining followed by the word "DNAtrix" whereas the letters DNA are uppercase and the letters "trix" are lowercase.
Color Claim
Color is not claimed as a feature of the mark.
Pseudo Mark
DNA TRIX; DNA TRICKS; DEOXYRIBONUCLEIC ACID TRIX
Classification
International Classes
045